Drugs used by some Type 2 diabetics may lessen risk for severe COVID-19 outcomes, study suggests

A type of drug already used to treat obesity and Type 2 diabetes, when taken six months prior to the diagnosis of COVID-19, was associated with a decreased risk of hospitalization, respiratory complications and death in COVID-19 patients with Type 2 diabetes, according to researchers.

source https://www.sciencedaily.com/releases/2021/09/210927132058.htm